Global Atherectomy Devices Market – Industry Trends and Forecast to 2032

Atherectomy Devices Market Size

• The global atherectomy devices market was valued at USD 976.00 million in 2024 and is expected to reach USD 1621.35 million by 2032
• During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.55%, primarily driven by rising prevalence of cardiovascular diseases (CVDs)
• This growth is driven by factors such as aging population, rising obesity & diabetes rates and unhealthy lifestyles

Atherectomy Devices Market Analysis

• Atherectomy devices are specialized medical tools used to remove plaque from arteries, improving blood circulation and reducing the risk of severe cardiovascular complications. These devices leverage advanced medical technology to enhance procedural precision, efficiency, and patient outcomes in the treatment of conditions such as peripheral artery disease (PAD) and coronary artery disease (CAD)
• The atherectomy devices market is expanding due to the rising prevalence of cardiovascular diseases, increasing preference for minimally invasive procedures, and continuous advancements in device technology
• Growing awareness of vascular health, coupled with favorable reimbursement policies and increased healthcare investments, is further driving market growth

• For instance, Medtronic and Boston Scientific have introduced next-generation atherectomy devices incorporating cutting-edge imaging and catheter-based solutions to improve treatment efficacy

• The atherectomy devices market is poised for continued growth, driven by advancements in vascular intervention technologies, rising demand for minimally invasive treatment options, and the increasing adoption of smart medical solutions. The focus on patient-centric innovations, cost-effective procedures, and regulatory compliance will further shape market expansion, with key industry players investing in research and development to maintain a competitive edge

Report Scope and Atherectomy Devices Market Segmentation        

Atherectomy Devices Market Trends

“Growing Adoption of Minimally Invasive Procedures”

• One prominent trend in the global atherectomy devices market is the growing adoption of minimally invasive procedures
• This trend is driven by the rising demand for faster recovery, lower procedural risks, and cost-effective treatments, driving medical device companies to innovate and develop advanced catheter-based atherectomy solutions that improve patient outcomes

• For instance, Philips has introduced the Turbo-Power™ Laser Atherectomy Catheter, which combines laser technology with advanced fiber optics to precisely target and remove arterial blockages, improving procedural outcomes

• As patients and physicians increasingly opt for minimally invasive vascular treatments, atherectomy devices are evolving with innovations such as real-time imaging, robotics integration, and AI-assisted guidance, ensuring better procedural efficiency and patient safety
• This shift is expected to accelerate advancements in atherectomy device technology, expand adoption in outpatient settings and ambulatory surgical centers (ASCs), and contribute to the market’s sustained growth as healthcare systems emphasize minimally invasive solutions for improved patient care

Atherectomy Devices Market Dynamics

Driver

“Increasing Geriatric Population”

• The growing geriatric population is a key driver of growth in the atherectomy devices market. As the global elderly population increases, the prevalence of age-related cardiovascular conditions such as peripheral artery disease (PAD) and coronary artery disease (CAD) is rising, leading to greater demand for effective vascular treatments, including atherectomy procedures
• This trend is particularly evident in regions such as North America, Europe, and Asia-Pacific, where aging demographics, coupled with advancements in healthcare infrastructure, are fueling the adoption of minimally invasive vascular interventions
• With elderly patients requiring safer and less invasive treatment options, atherectomy devices are evolving to offer improved precision, reduced procedural risks, and faster recovery times, making them a preferred choice for managing complex vascular conditions in aging populations
• The growing demand for age-specific cardiovascular care has led to significant investments in next-generation atherectomy technologies
• This includes AI-assisted imaging, real-time navigation systems, and drug-coated devices that enhance procedural effectiveness and patient outcomes

For instance,

• Cardiovascular Systems, Inc. (CSI) developed the Diamondback 360® Orbital Atherectomy System, designed to efficiently treat calcified arterial plaque in elderly patients with PAD, ensuring better vessel preparation before stent placement
• Boston Scientific’s Jetstream™ Atherectomy System has been widely adopted for its ability to effectively clear both soft and calcified plaque, reducing the need for additional interventions in high-risk elderly patients

• With increasing healthcare investments and advancements in age-focused vascular care, the atherectomy devices market is poised for sustained growth, as manufacturers continue to innovate and expand access to minimally invasive solutions that cater to the evolving needs of an aging global population

Opportunity

“Increasing Focus on Technological Advancements”

• The increasing focus on technological advancements, such as robotic-assisted atherectomy and AI-driven imaging, presents a significant opportunity for the atherectomy devices market. These innovations enhance precision, reduce procedure time, and improve patient outcomes, driving higher adoption rates among healthcare providers
• Leading medical device companies are investing in research and development (R&D) to integrate artificial intelligence, real-time navigation systems, and robotics into atherectomy procedures, allowing for more accurate plaque removal and reduced procedural risks
• Manufacturers are also partnering with healthcare systems, academic institutions, and AI firms to develop cutting-edge atherectomy solutions, fostering innovation and accelerating market growth

For instance,

• Medtronic has been exploring AI-powered imaging solutions to enhance intravascular visualization, enabling physicians to perform more precise atherectomy procedures
• RA Medical Systems has developed an advanced robotic laser system for atherectomy, improving operator control and reducing radiation exposure during procedures

• As the healthcare industry continues to embrace digital transformation, the integration of AI, robotics, and advanced imaging technologies in atherectomy devices offers a major opportunity to enhance procedural efficiency, expand market reach, and improve overall patient care

Restraint/Challenge

“Presence of Alternative Treatment Options”

• The presence of alternative treatment options, such as balloon angioplasty, stenting, and bypass surgery, poses a significant challenge for the atherectomy devices market. Many physicians and healthcare facilities continue to prefer these established methods due to their proven clinical outcomes and widespread availability
• Alternative procedures often have lower upfront costs, better reimbursement coverage, and are supported by extensive clinical data, making them more attractive to both patients and healthcare providers
• The continuous advancements in drug-coated balloons, bioresorbable stents, and other vascular intervention technologies create additional competition, potentially limiting the adoption of atherectomy devices in certain cases

For instance,

• Medtronic’s IN.PACT™ Admiral™ drug-coated balloon has demonstrated strong clinical efficacy in treating peripheral artery disease, offering a non-ablative alternative to atherectomy

• As alternative devices and treatment methods evolve, atherectomy device manufacturers must differentiate their offerings by demonstrating superior clinical benefits, improving cost-effectiveness, and expanding physician training programs to drive wider adoption in the vascular intervention market

Atherectomy Devices Market Scope

The market is segmented on the basis of product, application, and end user.

Atherectomy Devices Market Regional Analysis

“North America is the Dominant Region in the Atherectomy Devices Market”

• North America dominates the atherectomy devices market, driven by its well-established healthcare infrastructure, high adoption of advanced medical technologies, and a strong presence of key industry players. The region continues to lead in product innovation, regulatory approvals, and procedural advancements
• The U.S. holds a significant share due to its high prevalence of peripheral artery disease (PAD), rising geriatric population, and increasing demand for minimally invasive procedures
• Major medical device manufacturers, such as Medtronic, Boston Scientific, and Philips, are heavily investing in research and development, launching next-generation atherectomy solutions that enhance procedural efficiency and clinical outcomes
• In addition, the growing integration of AI-driven imaging, robotic-assisted atherectomy, and real-time data analytics is further strengthening North America’s leadership position in the market, improving both precision and patient safety in vascular interventions

“Asia-Pacific is Projected to Register the Highest Growth Rate”

• The Asia-Pacific region is expected to witness the highest growth rate in the atherectomy devices market, driven by increasing awareness of peripheral artery disease (PAD), rising healthcare expenditure, and growing adoption of minimally invasive procedures
• Countries such as China, India, Japan, and South Korea are experiencing a surge in demand for advanced vascular intervention technologies due to the rising prevalence of cardiovascular diseases and lifestyle-related disorders, such as diabetes and obesity
• Global medical device companies are expanding their presence in the region by forming strategic partnerships with local healthcare providers and regulatory bodies, facilitating faster product approvals and market penetration
• In addition, the increasing adoption of digital health technologies, including AI-powered diagnostic imaging, telemedicine for vascular care, and smart catheter-based interventions, is transforming the treatment landscape, positioning Asia-Pacific as the fastest-growing market for atherectomy devices

Atherectomy Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Koninklijke Philips N.V. (Netherlands)
• Medtronic (Ireland)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• BD (U.S.)
• Biomerics (U.S.)
• Catheter Precision Inc. (U.S.)
• Avinger (U.S.)
• Cardinal Health (U.S.)
• Terumo Europe NV (Belgium)
• Minnetronix Medical (U.S.)

Latest Developments in Global Atherectomy Devices Market

• In August 2021, Medtronic updated its HawkOne Directional Atherectomy System, originally launched in 2015, to strengthen its position in the global atherectomy devices market. The FDA-approved application update enhanced the device’s capabilities, contributing to increased adoption and reinforcing Medtronic’s competitive edge in the sector 

SKU-46576